Low frequency of colorectal dysplasia patients with long-standing inflammatory bowel disease colitis: Detection by flourescence edoscopy

Endoscopy

Volumn 38, Issue 5, 2006, Pages 477-482

  Ochsenkühn, Thomas ^a   Tillack, C ^a   Stepp, H ^a   Dlebold, J ^a   Ott, S J ^a   Baumgartner, R ^a   Brand, S ^a   Goke B ^a   Sackmann, M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AMINOSALICYLIC ACID; AZATHIOPRINE; BUDESONIDE; INFLIXIMAB; MERCAPTOPURINE; PHOTOSENSITIZING AGENT; PREDNISONE;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COLON BIOPSY; COLON DYSPLASIA; COLONOSCOPY; CROHN DISEASE; DISEASE COURSE; DYSPLASIA; ENDOSCOPY; FLUORESCENCE ANALYSIS; FLUORESCENCE ENDOSCOPY; FREQUENCY ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE MUCOSA; PRIORITY JOURNAL; REMISSION; ULCERATIVE COLITIS;

ADMINISTRATION, ORAL; ADULT; AGED; AMINOLEVULINIC ACID; BIOPSY; COLITIS; COLONOSCOPY; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORESCENCE; HUMANS; MALE; MIDDLE AGED; PHOTOSENSITIZING AGENTS; PRECANCEROUS CONDITIONS;

EID: 33646743143     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-925165     Document Type: Article

References (46)

1. Farrell RJ, Peppercorn MA. Ulcerative colitis. Lancet 2002; 359: 331-340
2. Rutter M, Saunders B, Wilkinson K et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004; 126: 451-459
3. Greenstein AJ, Sachar DB, Smith H et al. A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer 1981; 48: 2742-2745
4. Weedon DD, Shorter RG, Ilstrup DM et al. Crohn's disease and cancer. N Engl J Med 1973; 289: 1099-1103
5. Gyde SN, Prior P, Macartney JC et al. Malignancy in Crohn's disease. Gut 1980; 21: 1024-1029
6. Ekbom A, Helmick C, Zack M, Adami H-O. Increased risk of large bowel cancer in Crohn's disease with colonic involvement. Lancet 1990; 336: 357-359
7. Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 2001; 91: 854-862
8. Rhodes JM, Campbell BJ. Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol Med 2002; 8: 10-16
9. Ullman TA, Loftus EV Jr, Kakar S et al. The fate of low grade dysplasia in ulcerative colitis. Am J Gastroenterol 2002; 97: 922-927
10. Ransohoff DF, Riddell RH, Levin B. Ulcerative colitis and colonic cancer. Problems in assessing the diagnostic usefulness of mucosal dysplasia. Dis Colon Rectum 1985; 28: 383-388
11. Raithel M, Weidenhiller M, Schwab D et al. Pathobiology of dysplasia in chronic inflammatory bowel disease: Current recommendations for surveillance of dysplasia [in German]. Z Gastroenterol 2001; 39: 861-875
12. Messmann H. Fluorescence endoscopy in gastroenterology. Z Gastroenterol 2000; 38: 21-30
13. Stepp H, Sroka R, Baumgartner R. Fluorescence endoscopy of gastrointestinal diseases: basic principles, techniques and clinical experience. Endoscopy 1998; 30: 379-386
14. Sackmann M. Fluorescence diagnosis in GI endoscopy. endoscopy 2000; 32: 1-9
15. Messmann H, Endlicher E, Freunek G et al. Fluorescence endoscopy for the detection of low and high grade dysplasia in ulcerative colitis using systemic or local 5-aminolaevulinic acid sensitisation. Gut 2003; 52: 1003-1007
16. Messmann H, Knüchel R, Bäumler W et al. Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization. Gastrointest Endosc 1999; 49: 97-101
17. Messmann H, Kullmann F, Wild T et al. Detection of dysplastic lesions by fluorescence in a model of colitis in rats after previous photosensitization with 5-aminolaevulinic acid. Endoscopy 1998; 30: 333-338
18. Best WK, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. Gastroenterology 1976; 70: 439-444
19. Lichtiger S, Present DH, Kornbluth A et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N EngI J Med 1994; 330: 1841-1845
20. Shetty K, Rybicki L, Brzezinski A et al. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol. 1999; 94: 1643-1649
21. Kornfeld D, Ekbom A, Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut 1997; 41: 522-525
22. Marchesa P, Lashner BA, Lavery IC et al. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol. 1997; 92: 1285-1288
23. Batlle AM. Porphyrins, porphyrias, cancer and photodynamic therapy - a model for carcinogenesis. J Photochem Photobiol B 1993; 20: 5-22
24. Kennedy JC, Pottier RH. Endogenous protoporphyrin K a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 1992; 14: 275-292
25. Peng Q, Warloe T, Berg K et al. 5-Aminolevulinic acid-based photodynamic therapy. Cancer 1997; 79: 2282-2308
26. Kiesslich R, Fritsch J, Holtmann M et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003; 124: 880-888
27. Winther KV, Vruun E, Horn T et al. Screening for dysplasia in patients with 22-40 years of ulcerative colitis in a population-based cohort from Copenhagen County. Gastroenterology 2003; 124 (Suppl): A216
28. Rutter MD, Saunders BP, Schofield G, Forbes A, Price AB, Talbot IC. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004; 53: 256-260
29. Peppercorn MA, Odze RD. Colorectal cancer surveillance in inflammatory bowel disease. UpToDate 2006. www.uptodate.com
30. Arnott ID, Drummond HE, Ghosh S. Frequency of continuing mucosal inflammation in clinically inactive Crohn's disease. Scott Med J 2001; 46, 136-139
31. Beattie RM, Nicholls SW, Domizio P et al. Endoscopic assessment of the colonic response to corticosteroids in children with ulcerative colitis. J Pediatr Gastroenterol Nutr 1996; 22: 373-379
32. Riddell RH. Pathology of idiopathic inflammatory bowel disease. In: Kirsner JB (ed). Inflammatory bowel disease. 5th edn. Philadelphia: Saunders, 2000: 427-448
33. Connell WR, Lennard-Jones JE, Williams CB et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994; 107: 934-944
34. Melville DM, Jass JR, Shepherd NA et al. Dysplasia and deoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis. Observer variation and correlations. Gastroenterology 1988; 95: 668
35. Dixon MF, Brown LJ, Gilmour HM et al. Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology 1988; 13: 385
36. Lewis JD. The many faces of low-grade dysplasia. Gastroenterology 2003; 125: 1531-1533
37. van Hogezand RA, Eichhorn RF, Choudry A et al. Malignancies in inflammatory bowel disease: fact or fiction? Scand J Gastroenterol 2002; 236 (Suppl): 48-53
38. Fraser AG, Orchard TR, Robinson EM, Jewell DP. Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine. Aliment Pharmacol Ther 2002; 16: 1225-1232
39. Lynch DA, Lobo AJ, Sobala GM et al. Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993; 34: 1075-1080
40. Albert MB, Nochomovitz LE. Dysplasia and cancer surveillance in inflammatory bowel disease. Gastroenterol Clin N Am 1989; 18: 83-97
41. Axon AT. Cancer surveillance in ulcerative colitis: a time for reappraisal. Gut 1994; 35: 587
42. Ullman T, Croog V, Harpaz N et al. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 2003; 125: 1311-1319
43. Bernstein CN, Eaden J, Steinhart AH et al. Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid. Inflamm Bowel Dis 2002; 8: 356-361
44. Mir-Madjlessi SH, Farmer RG, Easley KA, Beck GJ. Colorectal and extracolonic malignancy in ulcerative colitis. Cancer 1986; 58: 1569-1574
45. Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992; 103: 1444-1451
46. Brand S, Wang TD, Schomacker KT et al. Detection of high-grade dysplasia in Barrett's esophagus by spectroscopy measurement of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence. Gastrointest Endosc 2002; 56: 479-487